RxDoctor Payments Data

Doshandra Nelson, MD

Family Medicine · Gaffney, SCNPI 1932334786

Payments from drug & device makers

$767in general payments, 2019–2025

Across 44 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$197
  • Amgen$88
  • Dexcom, Inc.$69
  • Pfizer$58
  • Novo Nordisk$49
  • AbbVie$49
  • plus $257 from 13 others

What the payments were for

  • Food & beverage$767100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$767 in reported general payments places this provider in the 55th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$794
Medicare patients
13
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$100,733
TrulicityDulaglutide46$68,081
JanuviaSitagliptin Phosphate66$49,788
LinzessLinaclotide65$45,199
EliquisApixaban28$32,271
JardianceEmpagliflozin26$25,328
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$21,497
XareltoRivaroxaban19$21,441
FarxigaDapagliflozin Propanediol28$18,886
MounjaroTirzepatide14$13,171
TrintellixVortioxetine Hydrobromide25$11,635
Dexlansoprazole DrDexlansoprazole22$8,214
Rosuvastatin Calcium395$7,758
Combivent RespimatIpratropium/Albuterol Sulfate13$6,256
Sucralfate28$6,222

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$49$100,733103 claims
MerckJanuvia$11$49,78866 claims
AbbVieLinzess, Synthroid$49$47,229100 claims
PfizerEliquis$58$32,27128 claims
Boehringer IngelheimJardiance, Combivent Respimat$12$31,58439 claims
GSKTrelegy Ellipta$20$21,49732 claims
Johnson & JohnsonXarelto$25$21,44119 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$12$11,63525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Gaffney

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →